These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1345020)
1. Postmarketing surveillance-one of the key issues in drug development. Székely G; Görgényi F Ther Hung; 1992; 40(4):147-53. PubMed ID: 1345020 [TBL] [Abstract][Full Text] [Related]
2. The role of databases in drug postmarketing surveillance. Rodriguez EM; Staffa JA; Graham DJ Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586 [TBL] [Abstract][Full Text] [Related]
3. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems. Glasser SP; Salas M; Delzell E J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697 [TBL] [Abstract][Full Text] [Related]
4. [Drug surveillance: concepts, objectives, and methods]. Susano RC; Laborinho Fialho L; de Quirós JF Acta Med Port; 1992 Dec; 5(11):595-602. PubMed ID: 1293954 [TBL] [Abstract][Full Text] [Related]
5. Post-marketing surveillance and adverse drug reactions. Shani S Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310 [No Abstract] [Full Text] [Related]
6. [Pharmacologic surveillance and safety evaluation of new drugs]. Reys LL Acta Med Port; 1991; 4(3):141-6. PubMed ID: 1950664 [TBL] [Abstract][Full Text] [Related]
7. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions. Fraunfelder FW; Fraunfelder FT Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050 [TBL] [Abstract][Full Text] [Related]
8. Reporting of adverse drug events: a key to postmarketing drug safety. Rheinstein PH Am Fam Physician; 1992 Sep; 46(3):873-4. PubMed ID: 1514478 [No Abstract] [Full Text] [Related]
9. Postmarketing surveillance versus clinical trials: which benefits the patient? Lawson DH Cardiology; 1994; 85 Suppl 1():18-23. PubMed ID: 7743530 [TBL] [Abstract][Full Text] [Related]
10. Global harmonization is not all that global: divergent approaches in drug safety. Castle GH; Kelly B Food Drug Law J; 2008; 63(3):601-22. PubMed ID: 19031662 [No Abstract] [Full Text] [Related]
11. [The need for 'postmarketing surveillance']. Stricker BH; in 't Veld BA; Feenstra J Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624 [TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions: a review of relevant factors. Ajayi FO; Sun H; Perry J J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248 [TBL] [Abstract][Full Text] [Related]
13. Research methods in drug surveillance. Engel RR; Grohmann R; Rüther E; Hippius H Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S12-5. PubMed ID: 15052510 [TBL] [Abstract][Full Text] [Related]
14. Safety of gadobenate dimeglumine (MultiHance): Summary of findings from clinical studies and postmarketing surveillance. Shellock FG; Parker JR; Venetianer C; Pirovano G; Spinazzi A Invest Radiol; 2006 Jun; 41(6):500-9. PubMed ID: 16763468 [TBL] [Abstract][Full Text] [Related]
15. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500 [TBL] [Abstract][Full Text] [Related]
16. Postmarketing surveillance. Oleen MA Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449 [TBL] [Abstract][Full Text] [Related]
17. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group. Faich GA; Castle W; Bankowski Z Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366 [TBL] [Abstract][Full Text] [Related]
18. [French system of drug surveillance]. Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332 [TBL] [Abstract][Full Text] [Related]
19. [Surveillance of secondary effects of vaccination]. Duclos P Sante; 1994; 4(3):215-20. PubMed ID: 7921691 [TBL] [Abstract][Full Text] [Related]